Eviprostat®N

Combination of 5 herbal extracts of Chimaphila umbellata, Pulsatilla pratensis, Populus tremula, Equisetum arvense and refined wheat Germ Oil.

Over-the-counter medicine.

DOWNLOAD PACKAGE LEAFLET

Local Pharmacies

Ein Service von: aponet.de - dem offiziellen Gesundheitsportal der deutschen Apothekerinnen und Apotheker

Online Pharmacies

Logo@500-160
logo (1)@500-160

Advantages

• Well-documented medicinal plants with a long history of traditional use.
• Safe and reliable, low adverse effect rate over many years of clinical practice.
• EU GMP certified manufacturing process guarantees the high quality.

Several experimental findings (in vitro and in vivo) demonstate the plausibility of using the combination of Eviprostat N in BPH.1

  • Chimaphila umbellata: Antiseptic, antioxidative, anti-inflammatory
  • Pulsatilla pratensis: Antiseptic, antioxidative, sedative
  • Populus tremula: Anti-inflammatory, antioxidative, analgetic, antiseptic
  • Equisetum arvense: Diuretic, anticonvulsive, antioxidant, antinociceptive
  • Refined wheat germ oil: Antioxidative, anti-inflammatory

Mandatory Information

Eviprostat N enteric coated tablets

1 tablet contains:

Active ingredients: Dry extract from fresh chimaphila umbellata (9,7-23:1) extraction solvent ethanol 90 % (V/V) 0,0235 mg;
mixed extract from fresh young leaves and bark of populus tremula (1:1) (15-25:1) extraction solvent ethanol 90% (V/V) 0,025 mg;
dry extract from fresh pulsatilla pratensis (18-36:1) extraction solvent ethanol 90% (V/V) 0,01 mg;
dry extract from equisetum arvense (5,6-6,3:1) extraction solvent ethanol 20% (V/V) 1,5 mg;
wheat germ oil, refined 15 mg

Area of application:

For improvement of urination complaints caused by benign prostate enlargement in elder men. Before use, serious diseases have to be excluded by a doctor.

Eviprostat N is a traditional herbal medicinal product registered for its indication only based on longstanding use. 

Contains sucrose, lactose and galactose.

For risks and side effects, please ask your doctor or pharmacist.

Reference:

1 Oka M, Tachibana M, Noda K, Inoue N, Tanaka M and Kuwabara K (2007). Relevance of anti-reactive oxygen species activity to anti-inflammatory activity of components of Eviprostat, a phytotherapeutic agent for benign prostatic hyperplasia. Phytomedicine 14, 465-472.